As part of its aggressive global expansion strategy, UPS Healthcare has recently completed several significant investments in Hungary to offer customers faster shipping times and greater flexibility as they look to grow their businesses in existing and new markets.
These investments include the addition of 13,000m2 of state-of-the-art warehousing space to its hub near Budapest.
Housing multiple validated temperature-controlled environments for a variety of temperature-sensitive medicines and biologics, this expansion means that UPS Healthcare’s campus has 37,000m2 of dedicated Healthcare space in the country.
“Biologics, specialty pharmaceuticals, and personalized medicine demand precise, temperature-controlled logistics to get patient-critical products where they need to be,” said Fredrik Jansson, Managing Director, Central & Eastern Europe, UPS Healthcare Europe.
“Sitting at the heart of some of the fastest-growing healthcare markets in the world, we’re expanding our network and quality services in Central & Eastern Europe for our customers to support their growth and success now and in the years to come.”
The additional warehouse space is complemented by a growing fleet of temperature-controlled vehicles which serve 32 countries in Central and Eastern Europe, as well as the launch of UPS Premier, a new service that prioritizes and tracks critical shipments to within 3 meters of their location anywhere in UPS’s global network.
The global market for biologic therapeutic drugs is set to increase from $285.5 billion in 2020 to $421.8 billion by 2025.
